Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluvastatin 20mg capsules
0212000M0AAAAAA
|
Fluvastatin sodium | Fluvastatin sodium | Cardiovascular System | 13,218 |
|
Fluvastatin 40mg capsules
0212000M0AAABAB
|
Fluvastatin sodium | Fluvastatin sodium | Cardiovascular System | 11,704 |
|
Fluvastatin 80mg modified-release tablets
0212000M0AAADAD
|
Fluvastatin sodium | Fluvastatin sodium | Cardiovascular System | 4,046 |
|
Lescol XL 80mg tablets
0212000M0BBACAD
|
Lescol | Fluvastatin sodium | Cardiovascular System | 89 |
|
Nandovar XL 80mg tablets
0212000M0BGAAAD
|
Nandovar XL | Fluvastatin sodium | Cardiovascular System | 5 |
|
Cadaff XL 80mg tablets
0212000M0BHAAAD
|
Cadaff XL | Fluvastatin sodium | Cardiovascular System | No data available |
|
Dorisin XL 80mg tablets
0212000M0BEAAAD
|
Dorisin | Fluvastatin sodium | Cardiovascular System | No data available |
|
Lescol 20mg capsules
0212000M0BBAAAA
|
Lescol | Fluvastatin sodium | Cardiovascular System | No data available |
|
Lescol 40mg capsules
0212000M0BBABAB
|
Lescol | Fluvastatin sodium | Cardiovascular System | No data available |
|
Luvinsta XL 80mg tablets
0212000M0BCAAAD
|
Luvinsta | Fluvastatin sodium | Cardiovascular System | No data available |
|
Pinmactil 80mg modified-release tablets
0212000M0BDAAAD
|
Pinmactil | Fluvastatin sodium | Cardiovascular System | No data available |
|
Stefluvin XL 80mg tablets
0212000M0BFAAAD
|
Stefluvin | Fluvastatin sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.